vedolizumab
takeda
['thanks']
 thanks for sharing. although we have stronger data with ifx, these studies are reassuring and validating that we can use other monoclonal antibodies also in case of issues ifx like access, side effects, and previous lor especially with antibodies. #ecco23
Gastroenterologist/ IBD specialist. Author:Crohn's & Colitis for Dummies.Governor American College Gastroenterology, Chair ACG PR Committee. Founder @ibdclub